Media & Resources

NEW YORK, NY, LA JOLLA and SOUTH SAN FRANCISCO, CA, SEATTLE, WA, August 17, 2011 — A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of…

Flexible, agile and generous funding structures needed to ensure  development and delivery of lifesaving new options for HIV prevention ROME July 19, 2011—In the last year, promising trial results and critical scientific breakthroughs have changed the HIV prevention landscape, providing new opportunities for both a broader response to the epidemic with new prevention options and…

The International AIDS Vaccine Initiative (IAVI) welcomes news of the positive results of the Partners PrEP study, a multinational clinical study evaluating the daily use of oral antiretroviral drugs to prevent HIV acquisition, a strategy known as pre-exposure prophylaxis (PrEP).  Partners PrEP involved 4,758 heterosexual HIV discordant couples, in which one partner is HIV positive,…

NEW YORK, July 7, 2011—The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of Margaret (Margie) McGlynn as President and Chief Executive Officer. McGlynn, who has been a member of the IAVI Board of Directors since July 2010, replaces Seth Berkley, IAVI’s Founding President and CEO. She will work with the Board…

IAVI Continues to Rank among Top 1% of Charities Nationwide NEW YORK, June 6, 2011—For the 10th consecutive year, the International AIDS Vaccine Initiative (IAVI) has been awarded a four-star rating from Charity Navigator, America’s largest independent evaluator of charities. This rating indicates that IAVI consistently executes its mission in a fiscally responsible way, with…

NEW YORK, June 3, 2011—Three decades ago on June 5 the Mortality and Morbidity Weekly Report of the U.S. Centers for Disease Control and Prevention carried an account of five previously healthy young gay men in Los Angeles who had developed a rare kind of pneumonia that typically afflicted only the severely ill, malnourished and…

NEW YORK, May 18, 2011—In the three decades since AIDS was first identified in a brief article in the Morbidity and Mortality Weekly Report issued by the US Centers for Disease Control and Prevention, the virus that causes this devastating disease has taken the world on a roller coaster ride. We have watched in dismay…

NEW YORK, May 12, 2011—The International AIDS Vaccine Initiative (IAVI) welcomes the news that a large, multinational clinical study led by the HIV Prevention Trials Network (HPTN) has demonstrated that oral antiretroviral therapy (ART) administered earlier in the course of infection can reduce the sexual transmission of HIV among discordant couples, or couples in which…